A recent study reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt traditional lifestyle regimens.
Published data in a major health publication demonstrates that while obese people often shed substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these treatments need to be cognizant of the danger of rapid rebound weight gain when the medication is stopped," warns lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to original weight within about one and a half years.
Weighing Treatments
The study, which looked at 37 of trials involving thousands of patients, compared the results of the injectable medications with older methods.
Scientists note that people who lose weight through lifestyle changes alone typically see a more gradual creep back—perhaps 100 grams monthly—after stopping.
The Reason for the Rapid Regain
Experts believe the way of the injections explains the amplified weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in hunger is no longer kept in check, making excessive eating a significant risk."
An Ongoing Disease?
Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals contend that, given the likelihood of weight regain, the treatment might need to be ongoing.
This perspective is echoed by drug manufacturers, who note that the results "emphasize the chronic nature of obesity," akin to managing conditions like diabetes.
Patient Testimonies
Users who have stopped the medication report a powerful return of hunger.
"It felt as if a trigger activating and you're instantly extremely hungry," recalled a patient.
This challenge is worsened if patients have not established permanent dietary or behavioural changes during therapy.
Widespread Adoption
Survey data indicate that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is more common among females than men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on integrated behavioural support.
